188 related articles for article (PubMed ID: 30135653)
1. Rapamycin Upregulates Connective Tissue Growth Factor Expression in Hepatic Progenitor Cells Through TGF-β-Smad2 Dependent Signaling.
Wu Y; Wang W; Peng XM; He Y; Xiong YX; Liang HF; Chu L; Zhang BX; Ding ZY; Chen XP
Front Pharmacol; 2018; 9():877. PubMed ID: 30135653
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor β induces expression of connective tissue growth factor in hepatic progenitor cells through Smad independent signaling.
Ding ZY; Jin GN; Liang HF; Wang W; Chen WX; Datta PK; Zhang MZ; Zhang B; Chen XP
Cell Signal; 2013 Oct; 25(10):1981-92. PubMed ID: 23727026
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
Yang F; Chung AC; Huang XR; Lan HY
Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256
[TBL] [Abstract][Full Text] [Related]
4. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
[TBL] [Abstract][Full Text] [Related]
5. Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes.
Weng HL; Ciuclan L; Liu Y; Hamzavi J; Godoy P; Gaitantzi H; Kanzler S; Heuchel R; Ueberham U; Gebhardt R; Breitkopf K; Dooley S
Hepatology; 2007 Oct; 46(4):1257-70. PubMed ID: 17657819
[TBL] [Abstract][Full Text] [Related]
6. Connective tissue growth factor expression after angiotensin II exposure is dependent on transforming growth factor-β signaling via the canonical Smad-dependent pathway in hypertensive induced myocardial fibrosis.
Wong CKS; Falkenham A; Myers T; Légaré JF
J Renin Angiotensin Aldosterone Syst; 2018; 19(1):1470320318759358. PubMed ID: 29575960
[TBL] [Abstract][Full Text] [Related]
7. Connective tissue growth factor induction by lysophosphatidic acid requires transactivation of transforming growth factor type β receptors and the JNK pathway.
Cabello-Verrugio C; Córdova G; Vial C; Zúñiga LM; Brandan E
Cell Signal; 2011 Feb; 23(2):449-57. PubMed ID: 20965247
[TBL] [Abstract][Full Text] [Related]
8. Connective tissue growth factor is a Smad2 regulated amplifier of transforming growth factor beta actions in hepatocytes--but without modulating bone morphogenetic protein 7 signaling.
Gressner OA; Lahme B; Siluschek M; Rehbein K; Weiskirchen R; Gressner AM
Hepatology; 2009 Jun; 49(6):2021-30. PubMed ID: 19309720
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism.
Rodríguez-Vita J; Sánchez-López E; Esteban V; Rupérez M; Egido J; Ruiz-Ortega M
Circulation; 2005 May; 111(19):2509-17. PubMed ID: 15883213
[TBL] [Abstract][Full Text] [Related]
10. The immunomodulator FTY720 and its phosphorylated derivative activate the Smad signalling cascade and upregulate connective tissue growth factor and collagen type IV expression in renal mesangial cells.
Xin C; Ren S; Eberhardt W; Pfeilschifter J; Huwiler A
Br J Pharmacol; 2006 Jan; 147(2):164-74. PubMed ID: 16299553
[TBL] [Abstract][Full Text] [Related]
11. [Transforming growth factor beta 1 modulates connective tissue growth factor expression via Smad2 signaling pathway in podocyte in vitro].
Huang HC; Liang Y; Cheng LJ
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):574-7. PubMed ID: 15144593
[TBL] [Abstract][Full Text] [Related]
12. IL-13 induces connective tissue growth factor in rat hepatic stellate cells via TGF-β-independent Smad signaling.
Liu Y; Meyer C; Müller A; Herweck F; Li Q; Müllenbach R; Mertens PR; Dooley S; Weng HL
J Immunol; 2011 Sep; 187(5):2814-23. PubMed ID: 21804025
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of TGF-beta on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytes.
Gressner OA; Lahme B; Demirci I; Gressner AM; Weiskirchen R
J Hepatol; 2007 Nov; 47(5):699-710. PubMed ID: 17629588
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin induces the TGFbeta1/Smad signaling cascade in renal mesangial cells upstream of mTOR.
Osman B; Doller A; Akool el-S; Holdener M; Hintermann E; Pfeilschifter J; Eberhardt W
Cell Signal; 2009 Dec; 21(12):1806-17. PubMed ID: 19666112
[TBL] [Abstract][Full Text] [Related]
15. TGFβ mediates collagen production in human CRSsNP nasal mucosa-derived fibroblasts through Smad2/3-dependent pathway and CTGF induction and secretion.
Shieh JM; Tsai YJ; Chi JC; Wu WB
J Cell Physiol; 2019 Jul; 234(7):10489-10499. PubMed ID: 30426494
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin regulates connective tissue growth factor expression of lung epithelial cells via phosphoinositide 3-kinase.
Xu X; Wan X; Geng J; Li F; Yang T; Dai H
Exp Biol Med (Maywood); 2013 Sep; 238(9):1082-94. PubMed ID: 23986222
[TBL] [Abstract][Full Text] [Related]
17. Smad3 and extracellular signal-regulated kinase 1/2 coordinately mediate transforming growth factor-beta-induced expression of connective tissue growth factor in human fibroblasts.
Leivonen SK; Häkkinen L; Liu D; Kähäri VM
J Invest Dermatol; 2005 Jun; 124(6):1162-9. PubMed ID: 15955090
[TBL] [Abstract][Full Text] [Related]
18. Vitamin E inhibits cyclosporin A-induced CTGF and TIMP-1 expression by repressing ROS-mediated activation of TGF-β/Smad signaling pathway in rat liver.
Balah A; Ezzat O; Akool ES
Int Immunopharmacol; 2018 Dec; 65():493-502. PubMed ID: 30391882
[TBL] [Abstract][Full Text] [Related]
19. Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor.
Lin SL; Chen RH; Chen YM; Chiang WC; Lai CF; Wu KD; Tsai TJ
J Am Soc Nephrol; 2005 Sep; 16(9):2702-13. PubMed ID: 15987746
[TBL] [Abstract][Full Text] [Related]
20. Balance of profibrotic and antifibrotic [corrected] signaling in nephrogenic systemic fibrosis skin lesions.
Schieren G; Gambichler T; Skrygan M; Burkert B; Altmeyer P; Rump LC; Kreuter A
Am J Kidney Dis; 2010 Jun; 55(6):1040-9. PubMed ID: 20430497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
